Publicacións en colaboración con investigadores/as de University of Glasgow (22)

2024

  1. Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

    Journal of Cardiac Failure

2023

  1. A foundation model for generalizable disease detection from retinal images

    Nature, Vol. 622, Núm. 7981, pp. 156-163

  2. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45

2021

  1. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1528-1553

2020

  1. Chondrobags: A high throughput alginate-fibronectin micromass platform for in vitro human cartilage formation

    Biofabrication, Vol. 12, Núm. 4

  2. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

  3. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials

    European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171

  4. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

    Neurological Research and Practice, Vol. 2, Núm. 1

2019

  1. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

    Nature Communications, Vol. 10, Núm. 1

  2. Connexins in cancer: bridging the gap to the clinic

    Oncogene, Vol. 38, Núm. 23, pp. 4429-4451

  3. Effects of serelaxin in patients with acute heart failure

    New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726

2018

  1. Biomimetic oyster shell–replicated topography alters the behaviour of human skeletal stem cells

    Journal of Tissue Engineering, Vol. 9

2017

  1. Nanotopography controls cell cycle changes involved with skeletal stem cell self-renewal and multipotency

    Biomaterials, Vol. 116, pp. 10-20

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Genome-wide associations for birth weight and correlations with adult disease

    Nature, Vol. 538, Núm. 7624, pp. 248-252

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

  2. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    PLoS ONE, Vol. 10, Núm. 4